Skip to main contentSkip to navigation
Sirius Investors
Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

IART
NASDAQHealthcare

Revenue Analysis - IART

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

IART Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Regenerative Skin And Wound

0.0% of total revenue

$373.0K

ENT

0.0% of total revenue

$0

Instruments

0.0% of total revenue

$0

Neurosurgery

0.0% of total revenue

$0

Private Label

0.0% of total revenue

$0

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
ENT
Instruments
Neurosurgery
Private Label
Regenerative Skin And Wound
12/31/2025$0$0$0$0$373.0K
9/30/2025$40.9M$50.2M$201.6M$25.5M$84.0M
6/30/2025$41.9M$53.1M$209.0M$26.9M$84.7M
3/31/2025$38.8M$51.0M$190.9M$27.2M$74.8M
12/31/2024$0$0$0$0$11.7M
9/30/2024$40.6M$54.2M$176.0M$29.6M$80.5M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Regenerative Skin And Wound-99.6%

Geographic Regions

Declining Regions
Asia Pacific-15.9%

Earnings Reports

Want to see how IART's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports